Richard Brudnick's Net Worth
$716 Thousand
Who is Richard Brudnick?
Richard Brudnick does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include VOLITIONRX LTD, Codiak BioSciences, Inc., Prime Medicine, Inc., Bioverativ Inc., and Scholar Rock Holding Corp.
SEC CIK
Richard Brudnick's CIK is 0001692359
Past Insider Trading and Trends
2017 was Richard Brudnick's most active year for acquiring shares with 8 total transactions. Richard Brudnick's most active month to acquire stocks was the month of January. 2017 was Richard Brudnick's most active year for disposing of shares, totalling 12 transactions. Richard Brudnick's most active month to dispose stocks was the month of January. 2024 saw Richard Brudnick paying a total of $0.00 for 186,547 shares, this is the most they've acquired in one year. In 2018 Richard Brudnick cashed out on 173,774 shares for a total of $362,483.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VOLITIONRX LTD (VNRX) Snapshot price: $0.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.21% | 5.63K |
—
|
—
| 27.94K | ||||
Form 4
| +13.33% | 2.63K |
—
|
—
| 22.31K | ||||
Form 4
| +18.31% | 3.05K |
—
|
—
| 19.69K | ||||
Form 4
| +10.93% | 1.64K |
—
|
—
| 16.64K | ||||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Codiak BioSciences, Inc. (CDAKQ) No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $3.4303
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bioverativ Inc. No price found
EVP, Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.95K |
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -9.26% | -2.34K |
$104.47 | -$244,781.46 | 22.95K |
Feb 22 - Feb 23
| |||
Form 4
| +11.49% | 2.61K |
$103.52 | -$117,702.24 | 25.3K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +8,728.02% | 22.43K |
$45.75 | -$226,235.40 | 22.69K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Scholar Rock Holding Corp (SRRK) Snapshot price: $8.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 13.5K |
—
|
—
| 13.5K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||